Basit öğe kaydını göster

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.

dc.contributor.authorErturk, Aybige
dc.contributor.authorSancar, Serap
dc.contributor.authorCulha, Meltem
dc.contributor.authorBasarir, Nur Sena
dc.contributor.authorYildiz-Pekoz, Ayca
dc.contributor.authorSahin, Gokben
dc.contributor.authorAkbal-Dagistan, Özlem
dc.date.accessioned2022-07-04T15:21:15Z
dc.date.available2022-07-04T15:21:15Z
dc.identifier.citationSahin G., Akbal-Dagistan Ö., Culha M., Erturk A., Basarir N. S. , Sancar S., Yildiz-Pekoz A., "Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.", Journal of pharmaceutical sciences, 2022
dc.identifier.issn0022-3549
dc.identifier.othervv_1032021
dc.identifier.otherav_aa719a03-3f90-4353-8b4b-a459bf27886c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/184162
dc.identifier.urihttps://doi.org/10.1016/j.xphs.2022.06.004
dc.language.isoeng
dc.titleAntivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.
dc.typeMakale
dc.relation.journalJournal of pharmaceutical sciences
dc.contributor.department, ,
dc.contributor.firstauthorID3432032


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster